Floatz logo

Autologous Cd19/Cd22 Car T Cells

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Instituto de Investigación Hospital Universitario La PazCell therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Precursor Cell Lymphoblastic Leukemia-Lymphoma cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Institute of Hematology & Blood Diseases Hospital, China
Phase 2B
Cyclophosphamide
Institute of Hematology & Blood Diseases Hospital, China
Phase 2B
FILGRASTIM
Janssen Research & Development, LLC
Phase 2B
ETOPOSIDE
Asan Medical Center
Phase 2B
MERCAPTOPURINE ANHYDROUS
Institute of Hematology & Blood Diseases Hospital, China
Phase 2B

View all 36 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →